Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Daily News

Most PCIs in US Now Done With Radial Access

Michael O'Riordan

July 10, 2025

News Daily News

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Michael O'Riordan

July 03, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

Presentation EuroPCR 2025

Final seven-year outcome of the COMPARE-ABSORB trial

Presenter: Pieter Smits

May 22, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News SCAI 2025

Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers

L.A. McKeown

May 07, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

Yael L. Maxwell

March 24, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

Presentation CTO 2025

Clinical Experience With a Novel Perfusion Balloon Catheter in Patients With Coronary Artery Perforation: Primary Results From the Ringer Clinical Study

Presenter: David Kandzari

March 01, 2025

Presentation CTO 2025

Multivessel Graft Coronary Heart Disease Treated With POBA and Cutting Balloon

Presenter: Marco Anzini

February 28, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

Presentation Cardiovascular Interventions 2024

AGENT DCB: Device and Data

Presenter: Paul S. Teirstein

November 11, 2024

Presentation Cardiovascular Interventions 2024

Drug Coated Balloons:Patient Selection, Technique, Outcomes

Presenter: Ajay J. Kirtane

November 11, 2024

Advertisement

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Most PCIs in US Now Done With Radial Access

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

Final seven-year outcome of the COMPARE-ABSORB trial

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Clinical Experience With a Novel Perfusion Balloon Catheter in Patients With Coronary Artery Perforation: Primary Results From the Ringer Clinical Study

Multivessel Graft Coronary Heart Disease Treated With POBA and Cutting Balloon

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

AGENT DCB: Device and Data

Drug Coated Balloons:Patient Selection, Technique, Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content